Projects per year
- 200 - 250 out of 381 results
Search results
-
Finished
-
Brevity: A Phase II Study of Brentuximab vedotin (SGN-35) using a response adapted design in patients with Hodgkin Lymphoma unsuitable for chemotherapy due to age, fraility or co-morbidity
Fenwick, N. & Siddique, S.
MILLENNIUM PHARMACEUTICALS INC
5/02/14 → 30/06/21
Project: Research
-
Stratified Medicine Matrix Trial - Stratified Medicine Programme 2
1/02/14 → 31/01/15
Project: Research
-
FP7_COLLAB_MERLIN
Newsome, P., Barton, D. & Windridge, D.
European Commission - Management Costs, European Commission
1/02/14 → 31/01/19
Project: Research
-
TIER - APhase I/II Study of Thiotepa, Ifosphamide, Etoposide & Rituximab for the treatment of relapsed & refractory primary central nervous system lymphoma
Siddique, S. & Jackson, A.
15/01/14 → 1/06/21
Project: Research
-
A Phase I Trial of NECTAR: Nelarabine, Etoposide, Cyclophosphamide in T-ALL Relapse
Erasmus Univesitair Medisch Centrum, BLOODWISE
4/11/13 → 3/01/21
Project: Research
-
Cancer Research UK Clinical Trials Unit (CRCTU)
Kearns, P., Billingham, L., Wheatley, K., Bowden, S., Steven, N., Rea, D. & Craddock, C.
1/10/13 → 30/09/18
Project: Research
-
NIHR Research Design Service Renewal
Thomas, N., Mathers, J., Roberts, T., Calvert, M., Deeks, J., Moore, D., Kearns, P. & Brocklehurst, P.
1/10/13 → 30/09/18
Project: Research
-
FP7 COLLAB - EEC
European Commission, European Commission - Management Costs
1/10/13 → 30/09/19
Project: Research
-
A Multi-Disciplinary Approach to Understanding the Immunological Basis and Potential Prevention of Graft versus Host Disease
Moss, P., Malladi, R., Craddock, C., Pratt, G., Smith, D. & Tino, P.
1/10/13 → 30/06/18
Project: Research Councils
-
Redirected Viral Immunotherapy for Acute Myeloid Leukaemia
Cobbold, M., Freeman, S., Kearns, P. & Weston, V.
9/09/13 → 8/09/16
Project: Research
-
-
Metabolomics for Risk Stratification in Neuroblastoma
McConville, C., Brundler, M., Peet, A., Wilson, M. & Kearns, P.
9/01/13 → 8/09/13
Project: Research
-
Mechanisms Central to the Development and Maintenance of Myeloid Disease: The Role of Myb Family Proteins and their Potential for Therapeutic Intervention
Frampton, J., Dumon, S., Garcia, P. & Kearns, P.
1/01/13 → 31/12/17
Project: Research
-
-
Aberrant Sphingolipid and Hedgehog Signalling in Gastric and Oesophageal Adenocarcinoma; New Opportunities to Stratify Patients for Targeted Therapies
Murray, P., Alderson, D., Dawson, C., Howman, A., Taniere, P., Tucker, O., Wei, W., Wheatley, K. & Young, L.
1/01/13 → 31/12/13
Project: Research
-
Discovery and Prioritisation of Frequently Mutated Genes in Tumour Cells of Paediatric Hodgkin's Lymphoma Through Whole Genome Amplification and Whole Exome Sequencing
Wei, W., Kearns, P., Murray, P. & Cader, Z.
BIRMINGHAM CHILDRENS HOSPITAL RESEARCH FOUNDATION
1/12/12 → 30/06/14
Project: Research
-
Characterising and Immunologically Targeting the Phosphoproteome in Myeloid Leukaemia
Cobbold, M., Craddock, C., Freeman, S. & Raghavan, M.
1/10/12 → 30/09/16
Project: Research
-
Trials Acceleration Programme (TAP) - Clinical Centre University Hospital Birmingham
Craddock, C.
6/06/12 → 31/12/16
Project: Research
-
De-iron: A phase 2 study of the efficacy and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent Myelodysplastic Syndromes
Siddique, S. & Fenwick, N.
NOVARTIS PHARMACEUTICALS UK LTD, BLOODWISE
1/06/12 → 31/07/20
Project: Research
-
-
ISSF 11/12 - Exploiting Nm23-H1 for the ex-vivo expansion of haemopoietic stem cells
1/04/12 → 31/03/13
Project: Research
-
(60MTHS)Renewal of ECMC at Birmingham
Tselepis, C., Middleton, G., Craddock, C., Moss, P., Steven, N. & Morton, D.
1/04/12 → 31/03/17
Project: Research
-
Squamous cell carcinoma prevention in organ transplant recipients using topical treatments (SPOT)
1/03/12 → 3/07/19
Project: Other Government Departments
-
Phase 1/2, open-label, randomized study of the safety, efficacy and pharmacokinetics of Letrozole plus PD 0332991 (oral CDK 4/6 inhibitor) and Letrozole single agent for the first-line treatment of ER Positive, HER2 negative ADVANCED Breast
Rea, D. & Stubbs, C.
Sandwell & West Birmingham Hospitals
1/01/12 → 31/12/14
Project: Research
-
-
Metastatic Castration Resistant Study (mCRPC Study) - RRA4286
Ford, D. & Stubbs, C.
Sandwell & West Birmingham Hospitals
6/11/11 → 31/12/14
Project: Research
-
(Ext of RHBD06608 & RHBD12673) A Large Randomised Assessment of the Relative Cost-Effectiveness of Classes of Drugs for Parkinson's Disease
Clarke, C. E., Rowland, N., Wheatley, K. & Windridge, D.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/11/11 → 31/01/22
Project: Other Government Departments
-
-
Randomized, Open Label Multi-Center Study Comparing Cabazitaxel at 20 mg/m2 and at 25 mg/m2 Every 3 Weeks in Combination with Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer Previously Treated... (Proselica)
Ford, D. & Stubbs, C.
Sandwell & West Birmingham Hospitals
1/08/11 → 30/06/18
Project: Research
-
aTTom: Adjuvant Tamoxifen Treatment Offer More? Follow-Up, Data Cleaning and Analysis
Rea, D., Handley, K. & Bowden, S.
1/08/11 → 31/07/16
Project: Research
-
(24MTHS)CRUK/11/014: LGG2: Co-operative Multicentre Study for Children and Adolescents with Low Grade Glioma
1/08/11 → 30/06/14
Project: Research
-
Early Phase Development Trial
Birmingham Childrens and Womens Hospital
1/05/11 → 30/04/12
Project: Research
-
Investigating Global MicroRNA Responses to Chemotherapy Agents in Childhood Acute Lymphoblastic Leukaemia
Weston, V. & Kearns, P.
1/04/11 → 30/06/14
Project: Research